192 related articles for article (PubMed ID: 19741149)
1. Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway.
Wacker MJ; Kosloski LM; Gilbert WJ; Touchberry CD; Moore DS; Kelly JK; Brotto M; Orr JA
J Pharmacol Exp Ther; 2009 Dec; 331(3):917-24. PubMed ID: 19741149
[TBL] [Abstract][Full Text] [Related]
2. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms.
Strittmatter F; Gratzke C; Weinhold P; Steib CJ; Hartmann AC; Schlenker B; Andersson KE; Hedlund P; Stief CG; Hennenberg M
Eur J Pharmacol; 2011 Jan; 650(2-3):650-5. PubMed ID: 21044618
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2-induced arrhythmias in the anesthetized rabbit.
Wacker MJ; Best SR; Kosloski LM; Stachura CJ; Smoot RL; Porter CB; Orr JA
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1353-61. PubMed ID: 16339832
[TBL] [Abstract][Full Text] [Related]
6. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.
Mumford AD; Dawood BB; Daly ME; Murden SL; Williams MD; Protty MB; Spalton JC; Wheatley M; Mundell SJ; Watson SP
Blood; 2010 Jan; 115(2):363-9. PubMed ID: 19828703
[TBL] [Abstract][Full Text] [Related]
7. Dominant role for calpain in thromboxane-induced neuromicrovascular endothelial cytotoxicity.
Quiniou C; Sennlaub F; Beauchamp MH; Checchin D; Lahaie I; Brault S; Gobeil F; Sirinyan M; Kooli A; Hardy P; Pshezhetsky A; Chemtob S
J Pharmacol Exp Ther; 2006 Feb; 316(2):618-27. PubMed ID: 16214879
[TBL] [Abstract][Full Text] [Related]
8. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
9. Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB.
Touchberry CD; Silswal N; Tchikrizov V; Elmore CJ; Srinivas S; Akthar AS; Swan HK; Wetmore LA; Wacker MJ
BMC Pharmacol Toxicol; 2014 Dec; 15():73. PubMed ID: 25519194
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
12. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.
Siangjong L; Gauthier KM; Pfister SL; Smyth EM; Campbell WB
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H382-92. PubMed ID: 23203967
[TBL] [Abstract][Full Text] [Related]
13. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 mediates the stimulation of inositol 1,4,5-trisphosphate production and intracellular calcium mobilization by bradykinin in neonatal rat ventricular cardiomyocytes.
Nakamura F; Minshall RD; Le Breton GC; Rabito SF
Hypertension; 1996 Sep; 28(3):444-9. PubMed ID: 8794831
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
Tosun M; Paul RJ; Rapoport RM
Eur J Pharmacol; 1997 Dec; 340(2-3):203-8. PubMed ID: 9537816
[TBL] [Abstract][Full Text] [Related]
17. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor.
Kelley-Hickie LP; Kinsella BT
Biochim Biophys Acta; 2006 Sep; 1761(9):1114-31. PubMed ID: 16956790
[TBL] [Abstract][Full Text] [Related]
18. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
19. Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase.
Zhang M; Song P; Xu J; Zou MH
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):125-32. PubMed ID: 20947827
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-zeta modulates thromboxane A(2)-mediated apoptosis in adult ventricular myocytes via Akt.
Shizukuda Y; Buttrick PM
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H320-7. PubMed ID: 11748077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
